DGAP-News

Balda AG reports significant growth during Q1 2014 / 2015 - Seite 2

Operating segments performance

In its America segment, the Balda Group generated EUR 10.9 million of sales
revenue in the period under review, compared with EUR 10.6 million in the
previous year. Segment EBITDA of EUR 0.7 million was nevertheless
significantly ahead of the previous year's EUR 0.5 million, a further
indication that the Group's efficiency measures are taking effect.

The Europe segment registered marked growth of 42.0 % during the first
quarter 2014 / 2015. The segment generated EUR 9.8 million of sales
revenue, compared with EUR 6.9 million in the prior-year period. This very
high expansion rate reflects higher article sales as a consequence of above
average deliveries to customers in the medical business. Segment EBITDA
stood at EUR 0.9 million after the first three months (previous year: EUR
0.8 million). The previous year was positive affected by EUR 0.4 million
non-operating items.

In the Other segment, general holding company costs resulted in a slight
EBITDA loss of EUR 0.1 million (previous-year period: EUR -0.2 million).


Outlook

The Balda AG Management Board has confirmed its forecast for the current
2014 / 2015 financial year: insofar as macroeconomic conditions do not
worsen significantly, and no other unforeseen negative events of
considerable impact for the Balda Group occur, the company is assuming that
its consolidated sales revenue will be recorded between EUR 73 million and
EUR 78 million. The Management Board is also aiming for a positive result
before interest and taxes (EBIT) and an EBIT margin in the low single-digit
percentage range.

For more information, please refer to the "Outlook" section in our annual
report for the 2013 / 2014 financial year.


Further and more detailed information can be found on the website of Balda
AG: www.balda-group.com/de

The latest quarterly report for Q1 2014 / 2015 can be downloaded from the
investor relations area of Balda's website.

Contact

Michael Pfister
Deekeling Arndt Advisors
Phone: [phone]
Mobile: [phone]
Mail: [e-mail]

About Balda

Balda (ISIN: DE0005215107) is a provider of first-class solutions in
plastics for demanding, high-quality applications in the fields of
healthcare, lifestyle, automotive and consumer electronics industries.
Balda has operating divisions in Europe and America and maintains
state-of-the-art production facilities at its headquarter in Bad
Oeynhausen, Germany as well as in the USA. The success of Balda, which
employs around 780 people, is based on the deployment of leading-edge,
cost-effective technologies, coupled with the trust-based and close
collaboration with customers.

www.balda-group.com



---------------------------------------------------------------------

12.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: Balda AG
Bergkirchener Str. 228
32549 Bad Oeynhausen
Germany
Phone: [phone] / 9 22-0
Fax: [phone]
E-mail: [e-mail]
Internet: www.balda.de
ISIN: DE0005215107
WKN: 521510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
München, Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
296619 12.11.2014